Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences
Norton Rose Fulbright Canada LLP
Last year, we discussed predictions of increased M&A activity in the cannabis sector, given the federal Liberal Government's push to legalize cannabis for recreational use.
Fasken Martineau
The Minister of Health and Social Services tabled Bill n° 148 – An Act to regulate generic medication procurement by owner pharmacists and to amend various legislative provisions during the October 5...
Torys LLP
On October 5, the Québec government introduced Bill 148, An Act to regulate generic medication procurement by owner pharmacists and to amend various legislative provisions.
Minden Gross LLP
Last week the City of Toronto squared off in court against a chain of illegal cannabis dispensaries operating within the City in a proceeding designed to shut the dispensaries down once and for all.
McMillan LLP
The CSA recently published CSA Staff Notice 51-352 Issuers with U.S. Marijuana-Related Activities detailing disclosure expectations for issuers involved in marijuana-related practices or activities ...
Deloitte
In June 2017, we published our report ‘Breaking the dependency cycle: Tackling health inequalities of vulnerable families' which explores how the social determinants of health...
Holland & Knight
The U.S. Department of Health and Human Services (HHS) has withdrawn a HIPAA rule that would have required controlling health plans (CHPs) to demonstrate compliance with certain HIPAA standards.
Poyner Spruill LLP
The use of criminal background checks is becoming more prevalent as a form of credentialing for both individual and institutional health care providers seeking licensure, certification or the benefits...
Sheppard Mullin Richter & Hampton
After months of veiled threats, President Trump formally announced that his Administration will cease funding Cost-Sharing Reduction ("CSR") payments, a key component of the Affordable Care Act...
Sheppard Mullin Richter & Hampton
Yesterday, Thursday, October 12th, on the heels of the recent and repeated failures to repeal and replace the ACA, President Donald Trump signed an executive order nominally aimed at increasing competition...
Smith Gambrell & Russell LLP
Late yesterday, the White House stated that it would immediately stop the funding for billions of dollars in Affordable Care Act (ACA) subsidies.
BakerHostetler
Several recently reported cases highlight the growing risk physicians face if they succumb to competitive pressures, especially offers of remuneration from labs, pharmacies, home health agencies...
BakerHostetler
With growing patient demands, advanced technology and payer restraints, healthcare providers are increasingly exploring management agreements with experienced companies to handle...
Dentons
Acting on his promise, communicated in a tweet earlier this week, that "[s]ince Congress can't get its act together on HealthCare, I will be using the power of the pen to give great HealthCare to many people - FAST
Seyfarth Shaw LLP
William Eck authored an October 12 article in Bloomberg BNA Health Care Fraud Report, "Escobar One Year Later: Implied Certification and Materiality Under the False Claims Act."
Day Pitney LLP
On June 2, 2017, the Survey and Certification Group at the Centers for Medicare & Medicaid Services (CMS) issued a memorandum entitled "Requirement to Reduce Legionella Risk in Healthcare Facility Water Systems to Prevent Cases and Outbreaks of Legionnaires' Disease."
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
Foley Hoag LLP
On October 12, 2017, President Trump signed an Executive Order (EO) entitled "Promoting Healthcare Choice and Competition Across the United States."
Seyfarth Shaw LLP
The Republicans made a last ditch effort to repeal the Affordable Care Act (ACA) the last week of September when they floated the latest iteration of proposed legislation under the Graham-Cassidy bill.
Smith Gambrell & Russell LLP
President Donald Trump signed an Executive Order that potentially weakens the Affordable Care Act (ACA).
Latest Video
Most Popular Recent Articles
Holman Webb
A genomic profile may help a doctor make personalised health decisions, but also raises a number of ethical challenges.
Holman Webb
There are significant legal issues to consider for marketers of therapeutic goods.
Norton Rose Fulbright Australia
The article considers the responses to some of the key recommendations and potential implications of these responses.
Corrs Chambers Westgarth
This article is an overview of key proposed IP changes, the likely impact and five takeaways for your organisation.
Shelston IP
The TPPA-11 is what remains of the Trans-Pacific Partnership (TPP) Free Trade Agreement following the US withdrawal.
Carroll & O'Dea
Despite the popularity of cosmetic procedures, the industry in Australia is less regulated than other areas of medicine.
Holman Webb
Future action for non-compliance with the ACL in the marketing of therapeutic goods may result in much higher penalties.
Holman Webb
The Appeal decision confirms the need to understand medical malpractice and civil liability policy terms and conditions.
Shelston IP
The outcome of consultation with the sector will not be known for some time and progress will be monitored with interest.
Holman Webb
This case provides clear guidance of the type of complaint which can easily be characterised as not made in good faith.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter